Streetbeat News

Partnerships

IPAR

Inter Parfums, Inc. (NASDAQ GS: IPAR) has announced an exclusive worldwide fragrance license for the Roberto Cavalli brand, effective from July 6, 2023. The Cavalli fragrance business will be managed by Interparfums Italia, a wholly owned subsidiary of Inter Parfums. The company plans to modernize and elevate the fragrance portfolio, with brand extensions planned for 2024 and a new women's scent in 2025.

Portfolio Pulse from Happy Mohamed

July 10, 2023 | 12:15 pm

GOEV

Canoo Technologies (NASDAQ:GOEV) has announced an expansion of its partnership with the U.S. Department of Defense's Defense Innovation Unit (DIU) to further develop a high-power battery pack. The partnership expansion follows successful testing and analysis of Canoo's patented technology. Canoo's proprietary battery system is modular and offers industry-leading performance features, supporting various military applications and configurations. The company also has a battery module manufacturing facility at MidAmerica Industrial Park in Pryor, Oklahoma, which will create over 200 advanced manufacturing jobs.

Portfolio Pulse from Happy Mohamed

July 10, 2023 | 12:12 pm

ALPP

NBTX

NEON

TIVC

Several stocks experienced significant movement in pre-market trading. Notable gainers include Nanobiotix S.A. (NBTX), which surged 59.3% after entering a license agreement with Janssen Pharmaceutical, and Alpine 4 Holdings, Inc. (ALPP), which gained 29.2% after its subsidiary received a $5.25m purchase order from a U.S. Government contractor. On the other hand, Neonode Inc. (NEON) and Tivic Health Systems, Inc. (TIVC) were among the biggest losers, falling 30.4% and 23.3% respectively.

Portfolio Pulse from Lisa Levin

July 10, 2023 | 12:11 pm

HOG

Harley-Davidson (NYSE:HOG) is considering using its Indian facilities to manufacture motorcycles for global markets. The company, which discontinued manufacturing operations in India in 2020, has partnered with Hero MotoCorp to sell imported bikes in the country. Their joint venture's first product, the X440, is aimed at challenging Royal Enfield's dominance in the premium bike category. Harley-Davidson's renewed focus on India comes amid increasing commercial and defense engagement between the US and India.

Portfolio Pulse from Arpit Nayak

July 10, 2023 | 12:10 pm

MXCT

MaxCyte, Inc. (NASDAQ:MXCT) and Vittoria Biotherapeutics have signed a strategic platform license (SPL) for MaxCyte's Flow Electroporation technology and ExPERT platform. Vittoria will obtain non-exclusive clinical and commercial rights to use the technology and platform, while MaxCyte will receive licensing fees and program-related revenue. Vittoria plans to file an investigational new drug application for their lead program, Viper 101, later this year.

Portfolio Pulse from Happy Mohamed

July 10, 2023 | 12:06 pm

GLMD

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) has announced a strategic partnership with OnKai to apply its artificial intelligence (AI) models for enrollment and execution of clinical trials in underserved communities. The collaboration will start with Galmed's Primary Sclerosing Cholangitis (PSC) clinical development program. The clinical development for PSC is expected to start with a Phase 2a study in the fourth quarter of 2023. OnKai's AI platform is anticipated to generate a comprehensive enrollment plan for each trial phase and support the trial in local clinics.

Portfolio Pulse from Happy Mohamed

July 10, 2023 | 12:06 pm

ICAD

iCAD, Inc. (NASDAQ:ICAD) is showcasing its ProFound AI Suite for breast cancer detection at the AHRA 2023 annual meeting. The suite includes ProFound AI Detection®, ProFound AI® Density Assessment, and ProFound AI® Risk. The company is also offering an ROI tool to help organizations measure the return on investment for adopting ProFound AI. Several healthcare providers, including Midstate Radiology Associates, Kettering Health, and Naugatuck Valley Radiology, have reported increased efficiency, standardized assessments, and improved patient care after adopting iCAD's solutions.

Portfolio Pulse from Happy Mohamed

July 10, 2023 | 12:05 pm

PRTK

Paratek Pharmaceuticals has announced a modification to its Project BioShield contract with the Biomedical Advanced Research and Development Authority (BARDA). The modification provides new development milestones for the next procurement of NUZYRA, a treatment for pulmonary anthrax. The next procurement will be split into two equal parts based on the achievement of specific development milestones. The first procurement will be triggered by positive data from a dose-ranging efficacy study in 2024. The second procurement will be triggered by positive data from two studies in 2024. The final procurement will be triggered by Paratek's receipt of sNDA approval from the FDA for the treatment of inhalation anthrax.

Portfolio Pulse from Happy Mohamed

July 10, 2023 | 12:04 pm

CBAT

CBAK Energy has announced a three-year partnership with Echom for a lithium-ion battery order worth RMB 180 million. The partnership is expected to boost CBAK Energy's revenues and market presence.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 12:01 pm

TDY

Mobilicom has received a commercial scale purchase order from Teledyne-FLIR for the initial production of drones for the US Department of Defense. The financial terms of the deal were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 11:18 am